These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2329525)

  • 1. Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker rat.
    Shaw WN; Mitch CH; Leander JD; Zimmerman DM
    J Pharmacol Exp Ther; 1990 Apr; 253(1):85-9. PubMed ID: 2329525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of simmondsin on food intake, growth, and metabolic variables in lean (+/?) and obese (fa/fa) Zucker rats.
    Flo G; Vermaut S; Darras VM; Van Boven M; Decuypere E; Kühn ER; Daenens P; Cokelaere M
    Br J Nutr; 1999 Feb; 81(2):159-67. PubMed ID: 10450335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.
    Vickers SP; Webster LJ; Wyatt A; Dourish CT; Kennett GA
    Psychopharmacology (Berl); 2003 Apr; 167(1):103-11. PubMed ID: 12632249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the opioid antagonist LY255582 on body weight of the obese Zucker rat.
    Shaw WN; Mitch CH; Leander JD; Mendelsohn LG; Zimmerman DM
    Int J Obes; 1991 Jun; 15(6):387-95. PubMed ID: 1653188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LY226936 administered orally and centrally to obese Zucker rats suppresses food intake and body weight gain.
    Shaw WN; Clemens JA; Panetta JA
    Obes Res; 1994 Sep; 2(5):458-68. PubMed ID: 16353597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
    Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of glutamine and dihydroxyacetone supplementation on food intake, weight gain, and postprandial glycogen synthesis in female Zucker rats.
    Obeid OA; Jamal ZM; Hwalla N; Emery PW
    Nutrition; 2006; 22(7-8):794-801. PubMed ID: 16730949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S 23521 decreases food intake and body weight gain in diet-induced obese rats.
    Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R
    Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants.
    Shaw WN
    Pharmacol Biochem Behav; 1993 Nov; 46(3):653-9. PubMed ID: 8278442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intracerebroventricular leptin administration on feeding and sexual behaviors in lean and obese female Zucker rats.
    Fox AS; Olster DH
    Horm Behav; 2000 Jun; 37(4):377-87. PubMed ID: 10860681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats.
    Larsen PJ; Vrang N; Petersen PC; Kristensen P
    Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin causes reduction of food intake and body weight gain and improvement of glucose intolerance in combination with dipeptidyl peptidase IV inhibitor in Zucker fa/fa rats.
    Yasuda N; Inoue T; Nagakura T; Yamazaki K; Kira K; Saeki T; Tanaka I
    J Pharmacol Exp Ther; 2004 Aug; 310(2):614-9. PubMed ID: 15039452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of body weight gain and plasma corticosterone levels in Zucker fatty rats using an orally active neuropeptide Y Y1 antagonist.
    Ishihara A; Kanatani A; Okada M; Hidaka M; Tanaka T; Mashiko S; Gomori A; Kanno T; Hata M; Kanesaka M; Tominaga Y; Sato NA; Kobayashi M; Murai T; Watanabe K; Ishii Y; Fukuroda T; Fukami T; Ihara M
    Br J Pharmacol; 2002 Jun; 136(3):341-6. PubMed ID: 12023935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats.
    Hayashi A; Sonoda R; Kimura Y; Takasu T; Suzuki M; Sasamata M; Miyata K
    Brain Res; 2004 Jun; 1011(2):221-7. PubMed ID: 15157808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateral hypothalamic serotonergic responsiveness to food intake in rat obesity as measured by microdialysis.
    Mori RC; Guimarães RB; Nascimento CM; Ribeiro EB
    Can J Physiol Pharmacol; 1999 Apr; 77(4):286-92. PubMed ID: 10535677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythms in the Zucker obese rat: assessment and intervention.
    Mistlberger RE; Lukman H; Nadeau BG
    Appetite; 1998 Jun; 30(3):255-67. PubMed ID: 9632457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE; Walker BR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate antagonists and eating behavior in humans: a review.
    de Zwaan M; Mitchell JE
    J Clin Pharmacol; 1992 Dec; 32(12):1060-72. PubMed ID: 1487543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin releasing hormone (TRH) potentiates the metabolic effect of norepinephrine (NE) in warm-acclimated lean and obese rats.
    al-Arabi A; Andrews JF
    Biomed Sci Instrum; 2003; 39():547-53. PubMed ID: 12724950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists.
    Emmerson PJ; McKinzie JH; Surface PL; Suter TM; Mitch CH; Statnick MA
    Eur J Pharmacol; 2004 Jun; 494(2-3):121-30. PubMed ID: 15212965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.